This inventor holds 1 USPTO granted patent. Top assignee: Advanced Protein Technologies Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kuo Jen Wu: Innovator in Dopamine-Related Therapeutics
Introduction
Kuo Jen Wu is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of medical science, particularly in the area of dopamine-related diseases. His innovative work focuses on developing compositions that can ameliorate, prevent, or treat conditions associated with reduced dopamine levels.
Latest Patents
Kuo Jen Wu holds a patent for a composition containing 2'-fucosyllactose (2'-FL) aimed at addressing diseases caused by a reduction in dopamine. This patent is particularly relevant for its application in preventing and treating Parkinson's disease. The composition effectively suppresses the degeneration of dopaminergic neurons, thereby improving motor activity in affected individuals. His patent is a testament to the potential of 2'-FL in therapeutic applications.
Career Highlights
Kuo Jen Wu is associated with Advanced Protein Technologies Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to tackling the challenges posed by dopamine deficiency. With a focus on practical applications, he aims to make a meaningful impact in the medical field.
Collaborations
Kuo Jen Wu collaborates with talented individuals such as Seong Jin Yu and Yun Wang. Their combined expertise contributes to the advancement of research and development in the field of dopamine-related therapeutics.
Conclusion
Kuo Jen Wu's contributions to the field of medical science, particularly through his patent on 2'-FL, highlight his commitment to addressing critical health issues. His work exemplifies the importance of innovation in developing effective treatments for diseases related to dopamine deficiency.